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To investigate the mechanism of ventricular arrhythmias
induced by epinephrine in dogs with hypokalemia, 30
adult mongrel dogs were separated into a control group
(n = 13) and a hypokalemia group (n = 17). In the
hypokalemia group, sodium polystyrene sulfonate (5 g/kg
body weight) was infused into the colon. In both groups,
the serum concentrations of sodium, potassium and cal-
cium were measured every 15 minutes for 60 minutes.
The mean (± standard deviation) serum potassium level
of the hypokalemia group decreased significantly from
3.81 ± 0.21 to 2.92 ± 0.36 mEq/liter; there were no
significant changes in other electrolytes. After 60 min-
utes, epinephrine (10 p,g/kg) was injected intravenously
in the hypokalemia and control groups, and the ar-
rhythmia ratio (the number of ventricular ectopic beats
divided by the total heart rate) was calculated for 5
minutes. Each group was further classified into subgroups
of dogs with an arrhythmia ratio higher or lower than
10%. An arrhythmia ratio over 10% was observed in
7.7% of the control group and 53% of the hypokalemia
group.
Immediately after 5 minutes of epinephrine injection,
Ventricular arrhythmias often develop in hypokalemia. Hol-
land et al. (1) analyzed 24 hour ambulatory electrocardio-
grams from 21 hypertensive patients treated with thiazide
diuretics and observed that complex ventricular arrhythmias
developed in 4 patients with hypokalemia. They reported
that these arrhythmias were abolished by potassium reple-
tion. Poole-Wilson (2) estimated that if 1 million hyperten-
sive patients were treated with thiazide diuretics, the life-
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myocardial mitochondria and plasma membrane frac-
tion were prepared from each group. Mitochondrial cal-
cium content and phospholipase activity of plasma mem-
brane fraction were determined. Significant increases in
both mitochondrial calcium content and phospholipase
activity were observed in the dogs with hypokalemia and
an arrhythmia ratio greater than 10%. In the hypoka-
lemia group, there was a clear reciprocal correlation
(r = - 0.79) between serum potassium concentration at
60 minutes and mitochondrial calcium content, and a
clear correlation (r = 0.80) between mitochondrial cal-
cium content and phospholipase activity. It was also
demonstrated that the dogs with a higher than 10%
arrhythmia ratio had a low serum potassium concen-
tration, high mitochondrial calcium content and high
phospholipase activity. These results suggest that hy-
pokalemia enhances the calcium influx induced by epi-
nephrine, resulting in activation of phospholipase, which
is responsible for the development of ventricular ar-
rhythmias.
(J Am Coli CardioI1986;8:1373-9)
threatening arrhythmias induced by the associated hypo-
kalemia would give rise to mortality rate of 450 patients a
year. Although the development of arrhythmias resulting
from hypokalemia is considered to be the major adverse
reaction during diuretic therapy (3,4), hypokalemia is not
only induced by thiazide therapy, but is one of the common
findings in acutely ill patients including those with myo-
cardial infarction. Indeed, malignant arrhythmias frequently
occur in hypokalemic patients with myocardial infarc-
tion (5-7).
Because ventricular arrhythmias may cause sudden death
(8,9), much interest has been attracted to the mechanisms
underlying the development of ventricular arrhythmias in
hypokalemic conditions. Duke (10) speculated that the hy-
pokalemia itself may contribute to the risk of arrhythmias,
whereas Thomas (11) suggested that the hypokalemia was
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Figure 1. Time course of changes in serum potassium (A), serum
sodium (B) and serum calcium (C) in each group. The serum
potassium level decreased significantly in the hypokalemia group,
but there was no significant change in serum sodium and calcium
throughout the experiment in each group. Values are means ±
SD. Control group (circles); hypokalemia group (triangles). **p
< 0.01 versus control.
Serum K+(mWt)
injection. Each group was classified into two subgroups
depending on the arrhythmia ratio: 1) arrhythmia ( +) (dogs
with an arrhythmia ratio of more than 10%), and 2) ar-
rhythmia ( -) (dogs with an arrhythmia ratio of less than
10%). For the purpose of this study, more than five suc-
cessive ventricular premature beats were defined as ven-
tricular tachycardia, and the total duration of ventricular
tachycardia was also measured for 5 minutes after epineph-
rine injection.
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Methods
related to another factor that was in itself arrhythmogenic.
Ventricular arrhythmias are also known to occur in patients
with myocardial infarction who show a high circulating level
of epinephrine (12), and Johansson and Dziamski (7) em-
phasized the role of epinephrine in the development of ar-
rhythmias in hypokalemic conditions. It was recently shown
(13-15) that arrhythmias may be associated with enhanced
activation of phospholipase. Consequently, the present study
was designed to clarify the genesis of ventricular arrhyth-
mias evoked in hypokalemic conditions in relation to both
the arrhythmogenic role of phospholipase and the relevant
effects of epinephrine.
Animal preparations. Thirty adult mongrel dogs of either
sex (weighing from 8 to 15 kg) were anesthetized with
sodium pentobarbital (50 mg/kg body weight) given intra-
peritoneally. After endotracheal intubation, artificial ven-
tilation was instituted with a Harvard ventilator using a
mixture of oxygen and room air. Lead II of the electrocar-
diogram was monitored continuously throughout the ex-
periment by a VC-640G oscillographic recorder (Nihon Ko-
den). The right femoral vein was dissected and cannulated.
The dogs were separated into two groups, a control (n =
13) and hypokalemia (n = 17) group. In the control group,
physiologic saline solution containing 0.15% (weight per
volume) potassium chloride was infused at a rate of 1.0
ml/min from the cannulated right femoral vein. In the hy-
pokalemia group, physiologic saline solution containing
0.02% (weight per volume) calcium chloride was infused
at a rate of 1.0 mllmin. A Nelaton catheter was inserted
into the colon. To cause hypokalemia, 5 g/kg of sodium
polystyrene sulfonate suspended in 200 ml of distilled water
was infused through the catheter. The two groups were
allowed 60 minutes for stabilization or induction of hypo-
kalemia.
Measurement of serum sodium, potassium and cal-
cium. At the beginning of the experiment and every 15
minutes thereafter for 60 minutes, the serum concentrations
of sodium, potassium and calcium were measured. Serum
sodium and potassium levels were determined by a Shi-
madzu CL-12 autoanalyzer, and serum calcium was deter-
mined by means of an orthocresolphthalein complexone (16)
using an autoanalyzer (Olympus AU550).
Epinephrine injection, measurement of the arrhyth-
mia ratio and total duration of ventricular tachycardia.
After the premedication period of 60 minutes, 10 j-tg/kg of
epinephrine was injected intravenously, and the appearance
of ventricular arrhythmias was observed for 5 minutes. The
severity of arrhythmias was expressed by the arrhythmia
ratio, that is, the number of ventricular ectopic beats divided
by the total heart rate during 5 minutes after epinephrine
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Table 1. The Number of Dogs Classified as Having an
Arrhythmia Ratio Greater Than (Arrhythmia [+ ]) and Less
Than (Arrhythmia [-]) 10% and the Incidence of Ventricular
Tachycardia in Each Group
VTdul1tian
(sec)
100
*Total duration time of ventricular tachycardia (mean :±: SO). rp <
0.05 versus control; :j:p < 0.01 versus control.
• ••
•
•
•
0 0 10 20 30 40 50
ArmyIhmic Ratio (%)
Arrhythmia ( + )
Arrhythmia ( - )
Ventricular tachycardia ( +)
Ventricular tachycardia ( - )
Control Group
(n = 13)
I
12
3 (6 :±: 2 s)*
10
Hypokalemia Group
(n = 17)
9:j:
8
I I:j: (32.9 :±: 17.6t s)*
6
50 • '-.--'y=1.8x-1.4(r=0.96)
:Arryhlhmic ralioii: 10%
o:Arrhylhmic ralio< 10%
[9 :mBan± SD
** :P<O.Ol
Hypokalemiao
high performance liquid chromatography with a fluorescent
detector (20). The 10 ILl solution of the fluorescent deriv-
atives of free fatty acids was injected into a Shimadzu-ODS
guard column (0.21 X 5 ern) plus Zolbax-ODS analytical
column (0.46 X 15 ern plus 0.46 X 25 em) at 60°C (back
pressure 80 kg/ern"; flow rate I ml/rnin; solvent methanol:
distilled water = 94.7:5.3). The fluorescent derivatives of
free fatty acids eluted from the column were detected by a
fluorescence spectromonitor (Shimadzu, RF-500LCA) con-
nected to a computerized recorder (Shimadzu, Chromato-
pac, C-RIA).
Measurement of mitochondrial calcium content. Heart
mitochondria were prepared by the method of Hatefi et al.
(21). Calcium content of myocardial mitochondria was mea-
sured by the method of Meissner et al. (22). Two milliliters
of the mitochondrial suspension (10 mg/ml protein) was
added to 2 ml of the solution of 1% LaCh/ I0% trichloro-
acetic acid, and centrifuged at 3,000 rpm .for 10 minutes.
The supernate was used to determine calcium content by an
Figure 4. H~a~ mitochondrial, calcium content in each group.
There was a significant Increase In the mitochondrial calcium con-
tent in the hypokalemia-arrhythmia (+) group (ratio 2: 10%) com-
pared with both control and hypokalemia-arrhythmia ( - ) groups.
(ratio < 10%).
60
Figure 3. Relation between arrhythmia ratio and total duration of
ventricular t~chycardia (VT) in the hypokalemia group. There is
a close relation between these two variables.
Epinephrine injection
+
1. j I ~~~~J..-,.J.....),J'J.tJw.MN.N.JJJJ.tJ.NJJl
;.J.,J,.ll.L~'lJV'VV'I1V\JV~J\I\I\I\I\I\,I\I\,I\I\,llIlI\
I I
~ig~re~. Repre~entative electrocardiogram after epinephrine in-
jection In a dog In the hypokalemia group. In most cases, ven-
tricul~r t~c~yc~rdia emerged abruptly within seconds after epi-
nephnne mjecnon, usually followed by ventricular bigeminy of
short duration.
Measurement of phospholipase activity. Five minutes
after epinephrine injection, a left thoracotomy was per-
formed and the heart was excised rapidly and washed several
times with cold physiologic saline solution. A plasma mem-
brane fraction was prepared according to the method of
Williams et al. (17), and phospholipase activity in the plasma
membrane fraction was estimated by a method previously
described (18). Using di-tridecanoyl phosphatidylcholine as
a substrate, the enzyme activity was determined by the amount
of tridecanoic acid released from the substrate. The plasma
membrane fraction (3 mg of protein) was added to 2 ILmol
of di-tridecanoyl phosphatidylcholine and incubated at 37°C.
After incubation for 30,60 and 90 minutes, tridecanoic acid
was extracted by a modified method of Folch et al. (19).
Heptadecanoic acid (100 ILmol) was used as an internal
standard. The extracted free fatty acids were redissolved
with 1.0 ml of 9-anthryldiazomethane (Funakoshi Phar-
maceutical) solution (0.5 mg/ml of methanol) and incubated
for 3 hours in the dark at room temperature. After conversion
to fluorescent derivatives by reaction with 9-anthryldiazo-
methane, the amount of tridecanoic acid was detected by
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Figure 6. Relation between serum potassium content after 60
minutes and mitochondrial calcium content in the control group
(A) and in the hypokalemia group (B). There is a clear reciprocal
correlation (r = -0.79) between serum potassium and mito-
chondrial calcium content in the hypokalemia group.
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in II (68%). A representative electrocardiogram after epi-
nephrine injection in a dog in the hypokalemia group is
shown in Figure 2. Ventricular tachycardia emerged abruptly
within seconds after epinephrine injection, usually followed
by ventricular bigeminy. Figure 3 shows a good correlation
(r = 0.96) between the arrhythmia ratio and the duration
of ventricular tachycardia in the hypokalemia group.
Calcium concentration in heart mitochondria (Fig. 4).
In the hypokalemia group, the calcium content of mito-
chondria prepared from the dogs classified as arrhythmia
(+ ) was significantly greater than that of mitochondria pre-
pared from the dogs classified as arrhythmia (-). In the
control group, only one dog showed an arrhythmia ratio of
more than 10%, but the mitochondrial calcium content was
elevated in this dog. In the untreated group, the mean
(± standard deviation) mitochondrial calcium content was
22.8 ± 3.6 nmol/mg protein. In the dogs classified as ar-
rhythmia ( - ) in both the control and hypokalemia groups,
no elevation of the mitochondrial calcium content was ob-
served in comparison with values in the untreated group.
Phospholipase activity (Fig. 5). Phospholipase activity
represents the amount of tridecanoic acid released from di-
Results
Figure 5. Phospholipaseactivity in myocardial plasma membrane
fraction in each group. A significant elevation of phospholipase
activity was observed in the hypokalemia-arrhythmia ( +) group
compared withbothcontrol andhypokalemia-arrhythmia ( - )groups.
Control-arrhythmia ratio ~ 10% (solid circle), < 10% (open
circle); hypokalemia-arrhythmia ratio ~ 10% (solid triangle), <
10% (open triangle) (mean ± SD). **p < 0.01 versus control-
arrhythmia ratio < 10%; * *p < 0.01 versus hypokalemia-
arrhythmia ratio < 10%.
Time course of changes in serum electrolytes (Fig. 1).
The mean (± standard deviation) concentration of serum
potassium (Fig. IA) significantly decreased in the 17 dogs
in the hypokalemia group from 3.81 ± 0.21 to 2.92 ±
0.36 mEq/liter, whereas in the 13 dogs in the control group
the serum potassium level did not change significantly
throughout the experiment. No significant change was ob-
served in the levels of serum sodium or calcium in either
group (Fig. IB and C).
Arrhythmia ratio and duration time of ventricular
tachycardia. Table I shows the number of dogs exhibiting
arrhythmia (arrhythmia ratio greater than 10%; arrhythmia
[+ ]) and those not exhibiting arrhythmia (arrhythmia ratio
less than 10%; arrhythmia [ - D in each group and the in-
cidence of ventricular tachycardia in each group. In the
control group, only I (7.7%) of the 13 dogs exhibited ar-
rhythmia, and ventricular tachycardia appeared in 3 (23%)
of them. In the hypokalemia group, 9 (53%) of the 17 dogs
exhibited arrhythmia and ventricular tachycardia appeared
atomic absorption spectrometer (Hitachi, 170-10). In the
other intact six dogs, heart mitochondrial calcium was also
measured for the untreated control condition.
Statistics. Significance of the results was determined by
Bonferroni's method except for the data from the dogs clas-
sified as arrhythmia (+) or arrhythmia (-) and for the
incidence of ventricular arrhythmias, where the chi-square
test was used. Probability (p) values of less than 0.05 were
considered statistically significant.
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Figure 8. Relation between arrhythmia ratioand serumpotassium
after 60 minutes in the control group (A) and in the hypokalemia
group (B). These figures reveal that in the dogs classified as ar-
rhythmia (+) (ratio ~ 10%), there is a low serum potassium
concentration.
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Figure 7. Relation between mitochondrial calcium content and
phospholipase activity in the control group (A) and the hypoka-
lemia group (B). There is a clear correlation (r = 0.80) in the
hypokalemia group.
tridecanoyl phosphatidylcholine by endogenous phospho-
lipase in the myocardial plasma membrane fraction. The
release of tridecanoic acid in each group appeared to increase
in linear fashion during the incubation period of 90 minutes.
A marked elevation was observed in the phospholipase ac-
tivity of the hypokalemia-arrhythmia ( + ) group (p < 0.0 I)
and in the control-arrhythmia ( +) group.
Relation between serum potassium and mitochondrial
calcium content (Fig. 6). There was a clear reciprocal
correlation (r = - 0.79) in the hypokalemia group (Fig.
6B). However, there was no significant correlation in the
control group (Fig. 6A).
Relation between the mitochondrial calcium content
and phospholipase activity (Fig. 7). There was a good
correlation between these variables (r = 0.80) in the hy-
pokalemia group (Fig. 7B). In the control group, there was
no significant correlation (Fig. 7A).
Relation among the arrhythmia ratio and serum po-
tassium, mitochondrial calcium and phospholipase ac-
tivity (Fig. 8 to 10). Results indicated that the dogs clas-
sified as arrhythmia (+) possess a low serum potassium
concentration, high mitochondrial calcium content and high
phospholipase activity.
Discussion
Hypokalemia and ventricular arrhythmias. Sudden
death is often observed in patients with hypokalemia and is
ascribed to the development of malignant cardiac arrhyth-
mias (8,9). In the present study, we demonstrated that 10
f.Lg/kg of epinephrine, which caused few ventricular ar-
rhythmias in the dogs with normokalemia, evoked severe
ventricular arrhythmias in more than half of the dogs with
hypokalemia. Thiazide and other potassium-depleting di-
uretic drugs are widely used to treat hypertension, conges-
tive heart disease and edematous conditions. Along with
their potential for benefit, these drugs have significant po-
tential for adverse effects including sudden death (9). The
mechanisms of hypokalemia-related cardiac arrhythmias have
been studied extensively, particularly from the electro-
physiologic viewpoint (23,24). Recently, to elucidate the
fundamental mechanisms involved in the genesis of cardiac
arrhythmias, the contributions of metabolic and biochemical
factors have been emphasized (25).
Arrhythmogenic mechanism of hypokalemia. In the
present study, we investigated the arrhythmogenic mecha-
nism of hypokalemia from a biochemical point of view. In
the hypokalemia group, the heart mitochondrial calcium
content in dogs with a high ventricular arrhythmia ratio was
elevated significantly compared with that of dogs with no
or only mild arrhythmia. A lower serum potassium level
and higher mitochondrial calcium content were observed.
It was pointed out (26) that calcium content in mitochondria
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Figure 9. Relation between arrhythmia ratio and mitochondrial
calcium content in the control group (A) and the hypokalemia
group (B). These figures show that thedogs classified as arrhythmia
(+) (ratio 2: 10%) possess a high mitochondrial calcium content.
is a reflection of increased intracellular calcium concentra-
tion . Calcium ion is known to be highly cardiotoxic (27),
and is suggested to play an important role in the genesis of
cardiac arrhythmias (28,29). In our study, dogs with higher
arrhythmia ratios had a higher mitochondrial calcium con-
tent. The injurious effect of calcium ion is, at least in part,
ascribed to the activation of endogenous phospholipase be-
cause the calcium ion is an essential factor for phospholipase
activation (30). In our experiment, in the hypokalemia group,
there was a good correlation between mitochondrial calcium
content and phospholipase activity . Accordingl y, intracel -
lular calcium overloading might be a responsible factor in
the activation of phospholipase in our model. Epinephrine
is well known to evoke arrhythmias (3 1), and this effect is
often used as an experimental model for arrhythmias (32).
Our present work now suggests a mechani sm for the ar-
rhythmogenic effect of epinephrine.
Role of phospholipase. Phospholipases are known to
play various physiologic roles (33, 34); howe ver , an en-
hanced activation of phospholipase may also induce several
pathologic conditions associ ated with the breakdown of
membrane phospholipids (35-38) . We demonstrated (39)
that phospholipase causes a deteriorat ion of the action po-
tential of the cardiac membrane and might induce arrhyth-
mogenic conditions. We also reported (40) that phospho-
lipase activity was accelerated in association with coronary
Figure 10. Relation between the arrhythmia ratio and phospho-
lipase activity in the control group (A) and in hypokalemia group
(B). These figures reveal that the dogs classified as arrhythmia
(+ ) (ratio 2: 10%) have a high phospholipase activity.
reperfusion , and suggested that the appearance of reperfu-
sion arrhythmias is closely related to the activation of phos-
pholipase . In the present study, the dog s with higher ar-
rhythmia ratios showed higher activity levels of phospholipase .
These results suggest that epinephrine-induced calcium in-
flux was accelerated in the hypokalemic condition, resulting
in phospholipase activation, which in turn was responsible
for the development of cardiac arrhythmias.
Clinical implications. In this study we demonstrated
that even relati vely small doses of epinephrine , which had
little or no effect on normokalemic dogs , evoked severe
ventricular arrhythmias in hypok alemic dogs, depending on
the degree of potassium depiction. Epinephrine itself in-
duced hypokalemia, but it must be emphasized that the
arrhythmogenic effect of epinephrine was enhanced in pre-
existing hypokalemic conditions. Although there are many
causes of hypokalemia , some cases are iatrogenic, caused
by diureti c therapy or dietary aberrations. Accordingly , sup-
plementation of serum potassium or the addition of potas-
sium-sparing diuretics should be considered , especially in
patients exhibiting an increa se in sympathetic tone. We also
demon strated that calcium influx and acti vation of phos-
pholipase are closely related to the development of ventri c-
ular arrhythmias in hypokalemia. Therefore , calcium an-
tagonists or antiphospholipase agents may be expected to
prevent these arrhythmias .
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